WSJ Health Forum

to
903 people attended
Welcome to The Wall Street Journal’s annual Health Forum. We’re delighted that you’ve joined us. Please see the event agenda here

The novel coronavirus is threatening populations, overwhelming healthcare systems and transforming social behavior so radically that economies have been sent into a tailspin. WSJ Health Forum will explore this crisis and much more. It will provide executives, investors, health professionals and industry experts with trusted insight from leaders in health policy and the health-care industries. Audience members will participate through Q&A sessions and will connect with each other to continue the conversation, exchange real-world knowledge and prepare for what’s next.

Proudly Supported By

Schedule

· Stage
WELCOME REMARKS
John Bussey
· Stage
THE GROUND BATTLE
Jeff Colyer Gerald F. Seib
· Stage
CASE STUDY: HEART DISEASE
Sekar Kathiresan, M.D. Nieca  Goldberg, M.D.  Betsy  McKay
· Stage
THE COST OF THE CURE
Peter Loftus Amy P.  Abernethy, M.D., Ph.D
· Stage
BEATING CANCER
Alexander Hardy Jonathan D.  Rockoff
· Stage
PREDICTING ILLNESS
Stephen  Hsu, Ph.D. Daniel J. Benjamin, Ph.D. Daniela  Hernandez
· Stage
GOING RETAIL
Larry  J. Merlo Anna  Wilde Mathews
· Sessions
THE COVID-19 CRISIS: HOW TO TACKLE
Nikki Waller Jeff Colyer
· Sessions
NEW DRUGS ARE EXPENSIVE, AND THEY DON'T ALWAYS WORK
Vinay Prasad, M.D. Ellie Austin
· Sessions
YOURS, MINE, OURS: SHARING CONSUMER HEALTH INFORMATION WITH INDUSTRY
Kayte  Spector-Bagdady Michelle Ma
· Stage
FIVE-MINUTE PROGRAM BREAK
· Stage
CORONAVIRUS AND THE HEALTHCARE SYSTEM
Stefanie  Ilgenfritz Howard A.  Zucker, M.D.
· Stage
INVESTING IN GLOBAL HEALTH
Trevor  Mundel Betsy  McKay
· Stage
GATTACA AND YOU
Kayte  Spector-Bagdady Richie  Etwaru Amy  Dockser Marcus
· Stage
IS GUN VIOLENCE A HEALTH ISSUE?
Patrice A.  Harris, M.D. Peter Loftus
· Sessions
3:36 pm TEST
Marcy  Darnovsky, Ph.D.
· Stage
CHASING CURES
Todd  Kuiken, Ph.D. Marcy  Darnovsky, Ph.D. Amy  Dockser Marcus
· Stage
RETHINKING HEALTH POLICY IN THE AGE OF CORONAVIRUS
Joshua M.  Sharfstein, M.D. Simon Johnson Greg  Ip
· Stage
THE POLICY PRESCRIPTION
Scott Gottlieb, M.D. Nancy-Ann  DeParle Anna  Wilde Mathews

Speakers

John Bussey
John Bussey

Associate Editor, The Wall Street Journal

Peter Loftus
Peter Loftus

Science Writer, The Wall Street Journal

Jonathan D.  Rockoff
Jonathan D. Rockoff

Deputy Bureau Chief, Health & Science, The Wall Street Journal

Daniela  Hernandez
Daniela Hernandez

Digital Science Editor, The Wall Street Journal

Anna  Wilde Mathews
Anna Wilde Mathews

Reporter, The Wall Street Journal

Amy  Dockser Marcus
Amy Dockser Marcus

Reporter, The Wall Street Journal

Betsy  McKay
Betsy McKay

Senior Writer, The Wall Street Journal

Greg  Ip
Greg Ip

Chief Economics Writer, The Wall Street Journal

Stefanie  Ilgenfritz
Stefanie Ilgenfritz

Bureau Chief, Health & Science, The Wall Street Journal

Marcy  Darnovsky, Ph.D.
Marcy Darnovsky, Ph.D.

Executive Director, Center for Genetics and Society

Richie  Etwaru
Richie Etwaru

Founder and CEO, Hu-manity.co

Anthony S.  Fauci, M.D.
Anthony S. Fauci, M.D.

Director, National Institute of Allergy and Infectious Diseases

Scott Gottlieb, M.D.
Scott Gottlieb, M.D.

U.S. Commissioner of Food and Drugs (2017-19); Resident Fellow, American Enterprise Institute

Alexander Hardy
Alexander Hardy

CEO, Genentech

Patrice A.  Harris, M.D.
Patrice A. Harris, M.D.

President, American Medical Association

Stephen  Hsu, Ph.D.
Stephen Hsu, Ph.D.

Senior Vice President for Research and Innovation, Michigan State University

Sekar Kathiresan, M.D.
Sekar Kathiresan, M.D.

Co-Founder and CEO, Verve Therapeutics

Todd  Kuiken, Ph.D.
Todd Kuiken, Ph.D.

Senior Research Scholar, Genetic Engineering and Society Center, North Carolina State University

Larry  J. Merlo
Larry J. Merlo

President and CEO, CVS Health

Trevor  Mundel
Trevor Mundel

President, Global Health Bill & Melinda Gates Foundation

Joshua M.  Sharfstein, M.D.
Joshua M. Sharfstein, M.D.

Professor of the Practice in Health Policy and Management; Johns Hopkins Bloomberg School of Public Health

Howard A.  Zucker, M.D.
Howard A. Zucker, M.D.

Commissioner, New York State Department of Health

Vinay Prasad, M.D.
Vinay Prasad, M.D.

Associate Professor of Medicine, Oregon Health and Science University

Amy P.  Abernethy, M.D., Ph.D
Amy P. Abernethy, M.D., Ph.D

Principal Deputy Commissioner, U.S. Food and Drug Administration

Jeff Colyer
Jeff Colyer

Governor, State of Kansas (2018-2019)

Nikki Waller
Nikki Waller

Editor, Live Journalism & Special Coverage, The Wall Street Journal

Ellie Austin
Ellie Austin

Editor, Live Journalism, The Wall Street Journal

Michelle Ma
Michelle Ma

Assistant Editor, Live Journalism, The Wall Street Journal

Gerald F. Seib
Gerald F. Seib

Executive Washington Editor, The Wall Street Journal

Simon Johnson
Simon Johnson

Professor, Global Economics and Management, MIT Sloan School of Management; Co-founder, COVID-19 Policy Alliance

Daniel J. Benjamin, Ph.D.
Daniel J. Benjamin, Ph.D.

Professor (Research) of Economics, and Director, Behavioral and Health Genomics Center, Center for Economic and Social R

Nancy-Ann  DeParle
Nancy-Ann DeParle

Director, White House Office of Health Reform (2009-2011); Administrator, Centers for Medicare and Medicaid Services (19

Nieca  Goldberg, M.D.
Nieca Goldberg, M.D.

Medical Director, NYU Women’s Heart Program; Senior Advisor, Women’s Health Strategy; Founder and Former Medical Directo

Kayte  Spector-Bagdady
Kayte Spector-Bagdady

Assistant Professor, Department of Obstetrics & Gynecology; Chief, Research Ethics Service, Center for Bioethics & Socia

The event is over

Hosted by

The Wall Street Journal

The Wall Street Journal is a U.S. business-focused, English-language international daily newspaper.

Booths

Boston Scientific

Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.

McDermott Will & Emery

McDermott Will & Emery

McDermott Will & Emery is the nation’s leading healthcare law firm.

PhRMA

PhRMA

PhRMA represents the country’s leading innovative biopharmaceutical research companies